Cannabinoids: A real prospect for pain relief?

Current Opinion in Pharmacology

Volumn 2, Issue 1, 2002, Pages 50-55

  Iversen, Leslie ^a   Chapman, Victoria ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 CHLOROPHENYL) 1 (2,4 DICHLOROPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; ANTINOCICEPTIVE AGENT; CANNABINOID; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; DELTA8 TETRAHYDROCANNABINOL DERIVATIVE; DEXANABINOL; DOPAMINE DERIVATIVE; DRONABINOL; DRUG RECEPTOR; FATTY ACID AMIDASE; G PROTEIN COUPLED RECEPTOR; METHANANDAMIDE; VANILLOID RECEPTOR;

AEROSOL; ALLODYNIA; ANALGESIA; ANIMAL; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATALEPSY; CONTROLLED STUDY; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG RESEARCH; DRUG SELECTIVITY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG USE; ELECTROPHYSIOLOGY; ENZYME DEFICIENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERALGESIA; HYPOALGESIA; KNOCKOUT MOUSE; LOCOMOTION; METABOLISM; MORTALITY; MOUSE; NEUROPATHY; NOCICEPTION; NONHUMAN; PAIN; PAIN ASSESSMENT; PHYSIOLOGY; RAT; DRUG ANTAGONISM; REVIEW;

ANIMALS; CANNABINOIDS; HUMANS; PAIN; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0036462447     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(01)00120-5     Document Type: Review

References (60)

1. Marijuana and Medicine: Assessing the Science Base
2. 1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: A double-label in situ hybridization study
3. Cannabinoid receptors undergo axonal flow in sensory nerves
4. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons
5. 1 receptor expression in rat spinal cord
6. Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder
7. The role of central and peripheral cannabinoid 1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain
8. 2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain
9. Spinal and supraspinal components of cannabinoid-induced antinociception
10. The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats
11. An analgesic circuit activated by cannabinoids
12. Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2
13. Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat
14. Cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses
15. Cannabinoid receptors and pain
16. 1 receptors
17. Control of pain initiation by endogenous cannabinoids
18. Cannabinoid inhibition of capsaicin-induced calcium response in rat dorsal root ganglion cells
19. Actions of cannabinoid receptor ligands on rat cultured sensory neurons: Implications for antinociceptions
20. Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases GTPyS binding in the dorsal horn of the spinal cord of non-inflamed and inflamed rats
21. 9-tetrahydrocannabinol-induced analgesia
22. Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN5 5,212-2
23. Cannabinoid modulation of dynorphin A: Correlation to cannabinoid-induced antinociception
24. Antihyperalgesic effects of spinal cannabinoids
25. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A
26. Anatomical basis for cannabinoid-induced antinociceptors as revealed by intracerebral microinjections
27. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: Evidence supporting periaqueductal gray involvement
28. Pain modulation by release of the endogenous cannabinoid anandamide
29. Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity
30. 1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurons in the rat
31. 1
32. 1 cannabinoid receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo
33. O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties
34. Pharmacological evaluation of aerosolized cannabinoids in mice
35. 1′1′-dimethylheptyl-Δ-8-tetrahydrocannabinol-11-oic acids: A novel, orally effective cannabinoid with analgesic and anti-inflammatory properties
36. Spinal cannabinoids are anti-allodynic in rats with persistent inflammation
37. The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain
38. The analgesic effects of R(+)-WIN55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain
39. 1 receptor upregulation in a rat model of chronic neuropathic pain
40. Increased mortality, hypoactivity and hypoalgesia in cannabinoid CB'1 receptor knockout mice
41. 2 receptor mediated actions in mouse brain
42. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain
43. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus
44. Supersensitivity to anandamide and enhanced endogenous cannabinoid signalling in mice lacking fatty acid amide hydrolase
45. Anandamide: Some like it hot
46. Induction of vanilloid receptor channel activity by protein kinase C
47. Anandamide excites central terminals of dorsal root ganglion neurones via vanilloid receptor 1 activation
48. Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel
49. The activity of anandamide at vaniloid VR receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism
50. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: Inhibitors of anandamide uptake with negligible capsaicin-like activity
51. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
52. The neurobiology and evolution of cannabinoid signalling
53. Two distinctive antinociceptive systems in rats with pathological pain
54. House of Lords Science and technology Second Report Therapeutic uses of cannabis
55. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review
56. Head group analogs of arachidonylethanolamide, the endogenous cannabind ligand J
57. 2): Identification of cannabinoid receptor subtype selective ligands
58. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
59. Cannabinoid agonists stimulate both receptor and non-receptor signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones
60. 2 cannabinoid receptor-mediated peripheral antinocieption